These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 427716)

  • 1. Combined chemoimmunotherapy for advanced breast cancer: a comparison of BCG and levamisole.
    Hortobagyi GN; Gutterman JU; Blumenschein GR; Yap HY; Buzdar AU; Tashima CK; Burgess MA; Hersh EM
    Cancer; 1979 Mar; 43(3):1112-22. PubMed ID: 427716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of disseminated breast cancer to combined modality treatment with chemotherapy and levamisole with or without Bacillus Calmette-Guérin.
    Hortobagyi GN; Yap HY; Blumenschein GR; Gutterman JU; Buzdar AU; Tashima CK; Hersh EM
    Cancer Treat Rep; 1978 Nov; 62(11):1685-92. PubMed ID: 728894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCG.
    Hortobagyi GN; Gutterman JU; Blumenschein GR; Tashima CK; Burgess MA; Einhorn L; Buzdar AU; Richman SP; Hersh EM
    Cancer; 1979 Apr; 43(4):1225-33. PubMed ID: 445325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCG.
    Hortobagyi GN; Gutterman JU; Blumenschein GR; Tashima CK; Burgess MA; Einhorn L; Buzdar AU; Richman SP; Hersh EM
    Cancer; 1979 Nov; 44(5):1955-62. PubMed ID: 387212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ifosfamide versus cyclophosphamide in combination drug therapy for metastatic breast cancer.
    Buzdar AU; Legha SS; Tashima CK; Yap HY; Hortobagyi GN; Hersh EM; Blumenschein GR; Bodey GP
    Cancer Treat Rep; 1979 Jan; 63(1):115-20. PubMed ID: 369682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoimmunotherapy of advanced breast cancer: prolongation of remission and survival with BCG.
    Gutterman JU; Cardenas JO; Blumenschein GR; Hortobagyi G; Burgess MA; Livingston RB; Mavligit GM; Freireich EJ; Gottlieb JA; Hersh EM
    Br Med J; 1976 Nov; 2(6046):1222-5. PubMed ID: 791447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemoimmunotherapy with FAC-BCG for metastatic breast cancer: the impact of CMF maintenance chemotherapy.
    Hortobagyi GN; Blumenschein GR; Buzdar AU; Yap HY; Schell FC; Barnes BC; Burgess MA
    J Surg Oncol; 1981; 18(2):163-72. PubMed ID: 7300363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of locoregionally advanced breast cancer with surgery, radiotherapy, and combination chemoimmunotherapy.
    Hortobagyi GN; Spanos W; Montague ED; Buzdar AU; Yap HY; Blumenschein GR
    Int J Radiat Oncol Biol Phys; 1983 May; 9(5):643-50. PubMed ID: 6343312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined chemoimmunotherapy and radiation therapy of inflammatory breast carcinoma.
    Krutchik AN; Buzdar AU; Blumenschein GR; Hortobagyi GN; Tashima CK; Gutterman JU; Yap HY; Hersh EM
    J Surg Oncol; 1979; 11(4):325-32. PubMed ID: 109703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy versus chemoimmunotherapy (CAF v CAFVP v CMF each +/- MER) for metastatic carcinoma of the breast: a CALGB study. Cancer and Leukemia Group B.
    Aisner J; Weinberg V; Perloff M; Weiss R; Perry M; Korzun A; Ginsberg S; Holland JF
    J Clin Oncol; 1987 Oct; 5(10):1523-33. PubMed ID: 3655855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ftorafur, adriamycin, cyclophosphamide and BCG in the treatment of metastatic breast cancer.
    Hortobagyi GN; Blumenschein GR; Tashima CK; Buzdar AU; Burgess MA; Livingston RB; Valdivieso M; Gutterman JU; Hersh EM; Bodey GP
    Cancer; 1979 Aug; 44(2):398-405. PubMed ID: 383255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of levamisole hydrochloride on advanced and recurrent breast cancer--LMS randomized controlled study of a group responding to CAF (cyclophosphamide, adriamycin, and 5-FU) therapy].
    Taguchi T; Izuo M; Ogawa N; Hayasaka H; Akai S; Tazima S; Fujii G; Tominaga T; Okamoto T; Kubo K; Yoshida M; Ota K; Sakai K; Hattori T; Inoue G; Nomura Y
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1595-608. PubMed ID: 6764119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant chemoimmunotherapy following regional therapy for isolated recurrences of breast cancer (stage IV NED).
    Buzdar AU; Blumenschein GR; Smith TL; Tashima CK; Hortobagyi GN; Yap HY; Gutterman JU; Hersh EM; Gehan EA
    J Surg Oncol; 1979; 12(1):27-40. PubMed ID: 480951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of levamisole immunotherapy and polychemotherapy in advanced breast cancer.
    Klefström P
    Cancer Treat Rep; 1980 Jan; 64(1):65-72. PubMed ID: 6991105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levamisole: as adjuvant to cyclic chemotherapy in breast cancer.
    Recent Results Cancer Res; ; . PubMed ID: 379932
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.